These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 6688402)
1. Absorption of phosphate in the jejunum of patients with chronic renal failure before and after correction of vitamin D deficiency. Davis GR; Zerwekh JE; Parker TF; Krejs GJ; Pak CY; Fordtran JS Gastroenterology; 1983 Oct; 85(4):908-16. PubMed ID: 6688402 [TBL] [Abstract][Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
3. Jejunal phosphate transport is not regulated by the PTH-adenylate cyclase system. Further studies on the contrasting features between intestinal and renal phosphate transport mechanisms. Lee DB; Walling MW; Palant CE; Tallos E Miner Electrolyte Metab; 1986; 12(5-6):293-7. PubMed ID: 3027518 [TBL] [Abstract][Full Text] [Related]
4. Magnesium absorption in the human small intestine. Results in normal subjects, patients with chronic renal disease, and patients with absorptive hypercalciuria. Brannan PG; Vergne-Marini P; Pak CY; Hull AR; Fordtran JS J Clin Invest; 1976 Jun; 57(6):1412-8. PubMed ID: 932189 [TBL] [Abstract][Full Text] [Related]
5. Jejunal and ileal absorption in patients with chronic renal disease. Effect of 1alpha-hydroxycholecalciferol. Vergne-Marini P; Parker TF; Pak CY; Hull AR; DeLuca HF; Fordtran JS J Clin Invest; 1976 Apr; 57(4):861-6. PubMed ID: 947957 [TBL] [Abstract][Full Text] [Related]
6. Influence of metabolic acidosis on serum 1,25(OH)2D3 levels in chronic renal failure. Lu KC; Lin SH; Yu FC; Chyr SH; Shieh SD Miner Electrolyte Metab; 1995; 21(6):398-402. PubMed ID: 8592483 [TBL] [Abstract][Full Text] [Related]
7. [Features of correction of phosphate-calcium metabolism disorders in terminal renal failure]. Pilotovich VS; Romanovich VP; Shilaĭ LM; Tukaĭ NN Klin Med (Mosk); 1992; 70(3-4):49-51. PubMed ID: 1507848 [TBL] [Abstract][Full Text] [Related]
8. Vitamin D deficiency is implicated in reduced serum albumin concentrations in patients with end-stage renal disease. Yonemura K; Fujimoto T; Fujigaki Y; Hishida A Am J Kidney Dis; 2000 Aug; 36(2):337-44. PubMed ID: 10922312 [TBL] [Abstract][Full Text] [Related]
9. Vitamin D deficiency in guinea pigs: exacerbation of bone phenotype during pregnancy and disturbed fetal mineralization, with recovery by 1,25(OH)2D3 infusion or dietary calcium-phosphate supplementation. Rummens K; van Bree R; Van Herck E; Zaman Z; Bouillon R; Van Assche FA; Verhaeghe J Calcif Tissue Int; 2002 Oct; 71(4):364-75. PubMed ID: 12196905 [TBL] [Abstract][Full Text] [Related]
10. Vitamin D deficiency and associated factors in hemodialysis patients. Jean G; Charra B; Chazot C J Ren Nutr; 2008 Sep; 18(5):395-9. PubMed ID: 18721733 [TBL] [Abstract][Full Text] [Related]
11. Kinetic analysis of D-xylose absorption in normal subjects and in patients with chronic renal failure. Craig RM; Murphy P; Gibson TP; Quintanilla A; Chao GC; Cochrane C; Patterson A; Atkinson AJ J Lab Clin Med; 1983 Mar; 101(3):496-506. PubMed ID: 6827177 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of vitamin D [25(OH)D] deficiency and effects of supplementation with ergocalciferol (vitamin D2) in stage 5 chronic kidney disease patients. Blair D; Byham-Gray L; Lewis E; McCaffrey S J Ren Nutr; 2008 Jul; 18(4):375-82. PubMed ID: 18558303 [TBL] [Abstract][Full Text] [Related]
13. Effect of cortisone on jejunal phosphate absorption in hypophysectomized rats. Yeh JK; Aloia JF Miner Electrolyte Metab; 1984; 10(6):398-403. PubMed ID: 6548794 [TBL] [Abstract][Full Text] [Related]
14. Jejunal absorption and secretion of calcium in patients with chronic renal disease on hemodialysis. Parker TF; Vergne-Marini P; Hull AR; Pak CY; Fordtran JS J Clin Invest; 1974 Aug; 54(2):358-65. PubMed ID: 4847249 [TBL] [Abstract][Full Text] [Related]
15. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues. Norman AW; Sergeev IN; Bishop JE; Okamura WH Cancer Res; 1993 Sep; 53(17):3935-42. PubMed ID: 8395333 [TBL] [Abstract][Full Text] [Related]
16. Why dialysis patients need combination therapy with both cholecalciferol and a calcitriol analogs. Jones G Semin Dial; 2010; 23(3):239-43. PubMed ID: 20492584 [TBL] [Abstract][Full Text] [Related]
17. Regulation of intestinal Na+-dependent phosphate co-transporters by a low-phosphate diet and 1,25-dihydroxyvitamin D3. Katai K; Miyamoto K; Kishida S; Segawa H; Nii T; Tanaka H; Tani Y; Arai H; Tatsumi S; Morita K; Taketani Y; Takeda E Biochem J; 1999 Nov; 343 Pt 3(Pt 3):705-12. PubMed ID: 10527952 [TBL] [Abstract][Full Text] [Related]
18. [Comparative studies of calcium resorption modified by vitamin D2 and D3 in patients with chronic renal failure and dialysis patients]. Fünfstück R; Günther K; Tietz U; Brandstädt A; Stein G; Hartwich R Z Urol Nephrol; 1986 Apr; 79(5):287-94. PubMed ID: 3017021 [TBL] [Abstract][Full Text] [Related]
19. Aluminum hydroxide, calcium carbonate and calcium acetate in chronic intermittent hemodialysis patients. Janssen MJ; van der Kuy A; ter Wee PM; van Boven WP Clin Nephrol; 1996 Feb; 45(2):111-9. PubMed ID: 8846523 [TBL] [Abstract][Full Text] [Related]
20. Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients. Lee SH; Huang TS; Hsieh SJ Miner Electrolyte Metab; 1996; 22(4):219-23. PubMed ID: 8807625 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]